Solara Active Pharma Sciences Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 25, 2025
SOLARA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Solara Active Pharma Sciences held its 8th Annual General Meeting on September 25, 2025, via video conferencing from 10:30 AM to 11:02 AM. Chairman Mr. R. Ramakrishnan presided, and MD & CEO Mr. Sandeep Shashikantha Rao presented the financial and operational performance for FY25. The auditors' report on the standalone and consolidated financial statements for the year ended March 31, 2025 contained no qualifications. Six resolutions were transacted, including adoption of audited financials, re-appointment of two directors, ratification of cost auditor remuneration, appointment of a secretarial auditor, and approval for material related party transactions with Strides Pharma Science Limited up to Rs. 400 crores. E-voting was conducted via CDSL from September 20 to 24, 2025, with results to be declared within two working days.
Routine AGM proceedings with no negative audit qualifications. The Rs. 400 crore related party transaction with Strides Pharma Science (the promoter group company) is a notable item but customary for Solara. No major surprises or negative signals — investors should await the e-voting results to confirm shareholder approval on each resolution.